Rising pharmaceutical expenditures have led to the use of cost-sharing measures. The
authors undertook a systematic review of the effects of cost sharing on vulnerable …

Background Canadians have long been proud of their universal health insurance system,
which publicly funds the cost of physician visits and hospitalizations at the point of care …

For over 30 years, Canadian provinces have provided universal public insurance for
hospital and physician care; however, evidence points to persisting socio-economic inequity …

Background. Prescription of new drugs contributes to substantial increases in annual drug
expenditures. A small proportion of physicians appear to be early users of new prescription …

OBJECTIVES: To describe recent changes and identify emergent trends in public drug
benefit policies in Canada from 2000 to 2010. METHODS: For each province, we tracked …

Canada's universal public healthcare system is unique among developed countries insofar
as it does not include universal coverage of prescription drugs. Universal, public coverage of …

Although the costs of doctors' visits and hospital stays in Canada are covered by national
public health insurance, the cost of outpatient prescription drugs is not. To solve problems of …

This paper describes and assesses pharmaceutical pricing and reimbursement policies in
Canada, considering them in the context of the broader policy and market environment in …

Background: Canadians spent almost $15 billion, over $460 per capita, on prescription
drugs in 2002, yet there is little published evidence regarding the nature and causes of …

Background Commentaries on the adequacy of insurance coverage for prescription drugs
available to Canadians have emphasized differences in the coverage provided by different …